IlluminaILMN

NASDAQ · USA · Segment 5 of 8 in the Medicine, pharma & life science value chain: Life science tools

DNA sequencing machines and the reagents they consume, for research and clinical genomics.

Life science tools: Instruments, reagents and equipment for research, development and production.

Key metrics

Market cap

$28.7B

Price

$223.22

Today

+1.7%

Return YTD

+67.3%

Return 1Y

+121.0%

P/E

34.7

P/S

6.4

P/B

10.1

Data as of 2026-08-25 · updates daily after U.S. close

Theme exposure

Genome sequencingLife science toolsDiagnostics exposureClinical genomics

In the value chain

Products & services

Sequencing instruments
Consumables (reagents)
Genomics software

Competitors

Thermo Fisher
PacBio
MGI

Risks

Competition in sequencing
Cyclical research demand

Supply chain

Supplies →

RegeneronREGN Vertex PharmaceuticalsVRTX NateraNTRA LabcorpLH Quest DiagnosticsDGX

Full supply chain for ILMN →

Same segment: Life science tools

Thermo Fisher ScientificTMO DanaherDHR Agilent TechnologiesA Waters CorporationWAT RevvityRVTY

Compare ILMN

ILMN vs TMO ILMN vs DHR ILMN vs A ILMN vs WAT ILMN vs RVTY

See where Illumina sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →